Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CASI Stock Summary
Top 10 Correlated ETFs
CASI
In the News
CASI Financial details
Company Rating
Neutral
Market Cap
34.84M
Income
-26.34M
Revenue
33.1M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
176
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-3.97
Forward P/E
-
PEG
1.32
P/S
3.4
P/B
1.99
P/C
-
P/FCF
-7.69
Quick Ratio
3.78
Current Ratio
4.32
Debt / Equity
0.81
LT Debt / Equity
0.78
-
-
EPS (TTM)
-2.02
EPS next Y
-
EPS next Q
-
EPS this Y
-30.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.73%
Revenue last 5Y
52.33%
Revenue Q/Q
-31.08%
EPS Q/Q
28.57%
-
-
-
-
SMA20
-
SMA50
-57.14%
SMA100
-40%
Inst Own
0%
Inst Trans
0%
ROA
-23%
ROE
-42%
ROC
0.07%
Gross Margin
67%
Oper. Margin
21%
Profit Margin
-88%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.85-8.48
52W High
-72.25%
52W Low
+122%
RSI
24
Rel Volume
0.19
Avg Volume
211.88K
Volume
40.4K
Perf Week
-29.07%
Perf Month
-62.31%
Perf Quarter
-33.33%
Perf Half Y
-17.78%
-
-
-
-
Beta
0.331
-
-
Volatility
0.23%, 0.74%
Prev Close
-5.13%
Price
2.22
Change
-3.48%
CASI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.43 | 1.37 | 2.22 | 3.16 | 2.54 | |
Net income per share | -5.36 | -5.66 | -2.78 | -2.89 | -2.02 | |
Operating cash flow per share | -2.42 | -2.34 | -1.97 | -1.55 | -1.49 | |
Free cash flow per share | -3.88 | -4.09 | -3.11 | -1.96 | -1.66 | |
Cash per share | 5.65 | 6.01 | 3.57 | 3.76 | 2.3 | |
Book value per share | 7.61 | 7.38 | 6.21 | 3.27 | 1.81 | |
Tangible book value per share | 8 | 8.18 | 7.04 | 4.83 | 1.67 | |
Share holders equity per share | 7.61 | 7.38 | 6.21 | 3.27 | 1.81 | |
Interest debt per share | 0.12 | 0.2 | 0.16 | 2.22 | 1.47 | |
Market cap | 296.48M | 325.83M | 108.88M | 24.43M | 95.66M | |
Enterprise value | 245.06M | 270.06M | 72.35M | -21.34M | 99.81M | |
P/E ratio | -5.77 | -5.21 | -2.88 | -0.62 | -3.55 | |
Price to sales ratio | 71.77 | 21.52 | 3.61 | 0.57 | 2.82 | |
POCF ratio | -12.76 | -12.59 | -4.06 | -1.16 | -4.79 | |
PFCF ratio | -7.96 | -7.21 | -2.57 | -0.91 | -4.31 | |
P/B Ratio | 4.06 | 4 | 1.29 | 0.55 | 3.96 | |
PTB ratio | 4.06 | 4 | 1.29 | 0.55 | 3.96 | |
EV to sales | 59.32 | 17.84 | 2.4 | -0.5 | 2.95 | |
Enterprise value over EBITDA | -7.8 | -16.66 | -2.26 | 2.8 | -3.58 | |
EV to operating cash flow | -10.54 | -10.43 | -2.7 | 1.01 | -5 | |
EV to free cash flow | -6.58 | -5.97 | -1.71 | 0.8 | -4.49 | |
Earnings yield | -0.17 | -0.19 | -0.35 | -1.61 | -0.28 | |
Free cash flow yield | -0.13 | -0.14 | -0.39 | -1.09 | -0.23 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.81 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.26 | |
Net debt to EBITDA | 1.64 | 3.44 | 1.14 | 6 | -0.15 | |
Current ratio | 7.74 | 9.28 | 4.7 | 4.32 | 3.55 | |
Interest coverage | 37.66 | 0 | 0 | -0.91 | 0 | |
Income quality | 0.51 | 0.54 | 0.75 | 0.52 | 0.74 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.01 | -0.02 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 6.62 | 1.3 | 0.79 | 0.54 | 0.75 | |
Research and developement to revenue | 2.36 | 0.76 | 0.48 | 0.37 | 0.26 | |
Intangibles to total assets | 0.16 | 0.1 | 0.09 | 0.01 | 0.02 | |
Capex to operating cash flow | 0.6 | 0.75 | 0.58 | 0.27 | 0.11 | |
Capex to revenue | -3.39 | -1.28 | -0.51 | -0.13 | -0.07 | |
Capex to depreciation | -6.51 | -9.87 | -8.54 | -2.32 | -0.6 | |
Stock based compensation to revenue | 1.77 | 0.52 | 0.26 | 0.16 | 0.21 | |
Graham number | 30.28 | 30.67 | 19.69 | 14.57 | 9.06 | |
ROIC | -0.59 | -0.52 | -0.42 | -0.59 | -0.69 | |
Return on tangible assets | -0.6 | -0.55 | -0.3 | -0.41 | -0.37 | |
Graham Net | 5.06 | 4.2 | 1.95 | 2.55 | -0.36 | |
Working capital | 53.55M | 66.05M | 48.78M | 56.42M | 42.62M | |
Tangible asset value | 76.77M | 90.36M | 95.76M | 65.87M | 22.33M | |
Net current asset value | 52.54M | 49.86M | 31.63M | 44.12M | 8.24M | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.81 | |
Average receivables | 646.5K | 2.97M | 7.22M | 11.39M | 11.56M | |
Average payables | 3.04M | 4.39M | 4.23M | 4.04M | 3.86M | |
Average inventory | 2.27M | 2.95M | 1.63M | 4.02M | 11.01M | |
Days sales outstanding | 114.24 | 111.98 | 118.61 | 109.85 | 109.22 | |
Days payables outstanding | 474.27 | 140.85 | 139.2 | 75.85 | 108.75 | |
Days of inventory on hand | 421.3 | 52.06 | 55.43 | 141.55 | 389.06 | |
Receivables turnover | 3.19 | 3.26 | 3.08 | 3.32 | 3.34 | |
Payables turnover | 0.77 | 2.59 | 2.62 | 4.81 | 3.36 | |
Inventory turnover | 0.87 | 7.01 | 6.58 | 2.58 | 0.94 | |
ROE | -0.7 | -0.77 | -0.45 | -0.88 | -1.11 | |
Capex per share | -1.46 | -1.75 | -1.14 | -0.41 | -0.17 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.13 | 0.63 | 0.74 | 0.66 | 0 | |
Net income per share | -1.37 | -0.45 | -0.77 | -0.35 | 0 | |
Operating cash flow per share | -0.06 | 0 | 0 | 0 | 0 | |
Free cash flow per share | -0.32 | 0 | 0 | 0 | 0 | |
Cash per share | 3.81 | 3.32 | 2.91 | 2.66 | 0 | |
Book value per share | 3.31 | 2.97 | 2.41 | 2.15 | 0 | |
Tangible book value per share | 4.89 | 4.6 | 3.99 | 3.75 | 0 | |
Share holders equity per share | 3.31 | 2.97 | 2.41 | 2.15 | 0 | |
Interest debt per share | 2.27 | 0 | 0 | 0 | 0 | |
Market cap | 24.09M | 30.95M | 33.36M | 34.25M | 0 | |
Enterprise value | -21.68M | 14.35M | 16.45M | 14.27M | 1.81M | |
P/E ratio | -0.33 | -1.29 | -0.81 | -1.85 | 0 | |
Price to sales ratio | 1.58 | 3.71 | 3.4 | 3.88 | 0 | |
POCF ratio | -28.58 | 0 | 0 | 0 | 0 | |
PFCF ratio | -5.64 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.54 | 0.78 | 1.04 | 1.19 | 0 | |
PTB ratio | 0.54 | 0.78 | 1.04 | 1.19 | 0 | |
EV to sales | -1.42 | 1.72 | 1.67 | 1.61 | 0.3 | |
Enterprise value over EBITDA | -1.73 | -2 | -1.98 | -2.64 | -0.92 | |
EV to operating cash flow | 25.72 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 5.08 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.77 | -0.19 | -0.31 | -0.14 | 0 | |
Free cash flow yield | -0.18 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.03 | 0 | 0 | 0 | 0.81 | |
Debt to assets | 0.01 | 0 | 0 | 0 | 0.26 | |
Net debt to EBITDA | -3.65 | 2.31 | 2.03 | 3.69 | -0.92 | |
Current ratio | 4.32 | 4.74 | 5.12 | 4.91 | 3.55 | |
Interest coverage | 0.4 | 0 | 0 | 0 | 0 | |
Income quality | 0.04 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.69 | 0.78 | 0.62 | 1.05 | |
Research and developement to revenue | 0.28 | 0.3 | 0.27 | 0.27 | -0.31 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0.02 | |
Capex to operating cash flow | 4.06 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.22 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -3.85 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.09 | 0 | 0 | 0 | 0 | |
Graham number | 10.12 | 5.48 | 6.46 | 4.1 | 0 | |
ROIC | 0.28 | -0.18 | -0.29 | -0.18 | -0.22 | |
Return on tangible assets | -0.19 | -0.07 | -0.13 | -0.06 | -0.07 | |
Graham Net | 2.59 | 2.3 | 2.1 | 1.87 | 0 | |
Working capital | 56.42M | 52.56M | 49.1M | 46.29M | 42.62M | |
Tangible asset value | 65.87M | 61.41M | 53.31M | 50.16M | 22.33M | |
Net current asset value | 44.12M | 40.42M | 36.97M | 34.32M | 8.24M | |
Invested capital | 0.03 | 0 | 0 | 0 | 0.81 | |
Average receivables | 12.77M | 12.04M | 11.82M | 12.09M | 10.9M | |
Average payables | 3.19M | 3.06M | 2.6M | 2.47M | 3.5M | |
Average inventory | 5.96M | 7.35M | 8.17M | 8.3M | 12.35M | |
Days sales outstanding | 76.52 | 119.77 | 114.83 | 118.7 | 149.8 | |
Days payables outstanding | 69.29 | 75.27 | 53.6 | 63.23 | 175.8 | |
Days of inventory on hand | 129.31 | 228.2 | 175.37 | 217.85 | 628.93 | |
Receivables turnover | 1.18 | 0.75 | 0.78 | 0.76 | 0.6 | |
Payables turnover | 1.3 | 1.2 | 1.68 | 1.42 | 0.51 | |
Inventory turnover | 0.7 | 0.39 | 0.51 | 0.41 | 0.14 | |
ROE | -0.41 | -0.15 | -0.32 | -0.16 | -0.23 | |
Capex per share | -0.25 | 0 | 0 | 0 | 0 |
CASI Frequently Asked Questions
What is CASI Pharmaceuticals, Inc. stock symbol ?
CASI Pharmaceuticals, Inc. is a US stock , located in Rockville of Md and trading under the symbol CASI
What is CASI Pharmaceuticals, Inc. stock quote today ?
CASI Pharmaceuticals, Inc. stock price is $2.22 today.
Is CASI Pharmaceuticals, Inc. stock public?
Yes, CASI Pharmaceuticals, Inc. is a publicly traded company.